Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term safety of Epoetin Hospira in hemodialysis patients
NCT01628107Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jul 2012
- Primary completion
- Jan 2015
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 2
01
Overview
A Phase 3 trial of epoetin alfa in anemia, sponsored by Pfizer. Started Jul 2012; status: completed.
02
Drugs
epoetin alfa
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01628107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01628107.